Gentel Biosciences recently launched its APiX Disease Profiling Kit. The kit contains a single-capture antibody array and is suitable for profiling hundreds of disease-related proteins across multiple disease states, Gentel said.
The kit combines Gentel's APiX chromogenic detection platform and Clontech's research-validated Antibody 380 array technology to help scientists study tumor-associated antigens, compare proteomic and transcriptomic data, and perform target identification and validation using an alternate readout to current fluorescent offerings, according to the firm.
The kit measures data using the Gentel Proteomics Multi-System and AthenaQuant analysis suite of software.
Randox Laboratories has launched two Metabolic Syndrome Arrays. The first biochip, Metabolic Syndrome Array I, includes analytes associated with metabolic syndrome, including: C-peptide, ferritin, IL-1α, IL-6, insulin, leptin, plasminogen activator inhibitor-I, resistin and tumor necrosis factor α.
Metabolic Syndrome Array II includes adiponectin, C-reactive protein, and cystatin C. The Metabolic Syndrome Arrays are suitable for use on plasma and serum, the company said.